Vimarsana
Biggest News Aggregation in the World

Page 4 - Prophase Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prophase Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prophase Lab Today - Breaking & Trending Today

ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022 - Vimarsana News

ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022

Garden City, NY, July 19, 2022 -- ProPhase Labs, Inc. , a diversified diagnostics and genomics company, today announced that it will host a live webcast on Thursday, July 21, 2022, at 11:30 a.m.... | July 19, 2022

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology - Vimarsana News

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology - read this article along with other careers information, tips and advice on BioSpace

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology - Vimarsana News

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology

28.06.2022 - Company Also Announces First Licensing Agreement for PBIO with Global BioLife, Inc. for broad based Anti-Viral Fighting Compounds Equivir and Equivir G Garden City, NY, June 28, 2022 (GLOBE NEWSWIRE) - ProPhase Labs, Inc. (NASDAQ: PRPH), a ... Seite 1

$18.05 Million in Sales Expected for ProPhase Labs, Inc. (NASDAQ:PRPH) This Quarter - Vimarsana News

$18.05 Million in Sales Expected for ProPhase Labs, Inc. (NASDAQ:PRPH) This Quarter

Analysts expect that ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) will post $18.05 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for ProPhase Labs’ earnings, with the lowest sales estimate coming in at $13.39 million and the highest estimate coming in at $22.70 million. ProPhase Labs […]

Zacks: Brokerages Expect ProPhase Labs, Inc. (NASDAQ:PRPH) to Announce $0.17 EPS - Vimarsana News

Zacks: Brokerages Expect ProPhase Labs, Inc. (NASDAQ:PRPH) to Announce $0.17 EPS

Wall Street brokerages expect ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) to report earnings per share of $0.17 for the current quarter, according to Zacks. Two analysts have issued estimates for ProPhase Labs’ earnings, with the highest EPS estimate coming in at $0.21 and the lowest estimate coming in at $0.12. ProPhase Labs reported earnings […]